NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/22/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization938.74 mln
Float21.00 mln
Earnings Date08/06/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.97
Likely reliable
1-Year Forecast
42.67
Strong upside
Relative Strength
91
/ 100
Top performer
Debt / Equity
1.02
Elevated leverage
Pre-Tax Margin
2%
Break-even
Business Description
Eton Pharmaceuticals is a US-based company founded in 2017 and headquartered in Deer Park, Illinois, that specializes in treatments for rare and often underserved medical conditions. The company currently sells eight approved products targeting disorders such as Wilson disease, adrenal insufficiency, and several metabolic conditions. Eton also has a pipeline of five additional treatments in advanced development, covering conditions including neonatal diabetes and adrenal crisis.
